Long Island Capital Alliance Announces Participants for Health Care Capital Forum

Long Island Capital Alliance Announces Participants for Health Care Capital 
Forum 
Event Held on March 8 in Collaboration With The Center for Advanced
Sensor Technologies at Stony Brook University 
MELVILLE, NY -- (Marketwire) -- 03/04/13 --  The Long Island Capital
Alliance ("LICA"), the leading non-profit capital formation and
business development organization serving regional companies, today
announced the presenting companies and panelists for its Health Care
Capital Forum to be held on March 8, 2013. The capital forum will be
held in collaboration with The Center for Advanced Sensor
Technologies at Stony Brook University. 
The presenting companies to be showcased at LICA's Health Care
Capital Forum were selected by LICA for this event from a wide
selection of developing medical technology, life sciences and health
care information technology companies on Long Island and the nearby
region. Several of the presenting companies provide best-in-class
solutions to enhance medical related diagnostics and therapies as
well as health care administration and productivity advancements.
These exciting health care companies are in need of private
investment and other business development assistance. Each of the
companies selected for presentation will provide a discussion of
their technology, product or service, a financial overview and
catalysts for significant growth. A panel of health care investors
will also participate in the event. The panel will provide insights
on presenting companies' business plans and investment potential, as
well as a review of the current investment climate for health care
companies. 
Health Care Capital Forum on March 8, 2013 - Participants 
Panel of Investors 
Larry Chaityn: Larry Chaityn is a Managing Director and Head of
Global Health care Banking at Kaminski Partners, a global investment
bank. He is responsible for overseeing the day-to-day operations of
the bank including deal sourcing, deal review, due diligence
investigation and client-facing operations. He has 14 years of health
care/life sciences advisory experience, is an active member in the
venture capital and angel investment communities and in the National
Association of Health Services Executives. 
Rusty Ray: Rusty Ray is a partner with 11T Partners, a health
care-focused investment bank. He has worked with a wide variety of
clients in the health care industry ranging from large pharmaceutical
companies to early-stage drug development companies to medical device
and service-based companies. Prior to forming 11T Partners, Mr. Ray
was a Partner with Brocair Partners, a health care investment banking
boutique. 
Paul Smolevitz: Paul Smolevitz is a Managing Director and was a
founding partner of TM Capital Corp in 1989. Since then, he has led
TM Capital's execution of many complex transactions, including
financings, strategic acquisitions, restructurings and fairness
opinions. Previously, Paul served as a Vice President at Thomson
McKinnon Securities Inc. and as a Senior Accountant at Deloitte &
Touche. He is a graduate of the Wharton School of the University of
Pennsylvania and earned an MBA from the Harvard Business School. 
Steve Winick: Steve Winick is a principal of Topspin Partners, one of
Long Island's leading venture capital firms. Steve previously served
as CIO of Honeywell International's $2B security group. He had been
with Honeywell (and the Ademco division of Pittway Corp., before its
acquisition by Honeywell in 2000) for over 21 years as CTO of the
security business, as well as founder and president of its wireless
communications services business. 
Presenting Companies 
AdhereTech: The company has patented smart pill bottles that increase
medication adherence. These bottles measure the exact amount of pills
or liquid in the bottle in real-time, wirelessly send this
HIPAA-compliant data into the cloud, and remind patients to take
their medication via automated phone call or text message. This
process increases adherence, leads to reductions in expensive patient
procedures and hospital readmissions, and requires zero setup for
patients. The open architecture of AdhereTech's technology can
integrate with all existing apps, programs, and adherence solutions.
Its servers record anonymized, HIPAA-compliant adherence data for
patients based on drug, disease state, and demographic. 
Wow Factor: AdhereTech has created patented smart pill bottles that
increase medication adherence. These bottles measure the exact number
of pills or liquid in the bottle in real-time, wirelessly send this
HIPAA-compliant data into the cloud, and remind patients to take
their medication via phone call or text.  
Venus Pharmaceuticals International: Venus Pharmaceuticals is a FDA
registered and cGMP compliant nutraceutical manufacturing facility.
Based in Hauppauge, NY, the Company specializes in the formulation
and production of all major forms of functional foods, and is now
expanding into micro-algae based biopharmaceuticals. 
Wow Factor: Venus Pharmaceuticals International, Inc., a
well-established pharmaceuticals manufacturer, has developed a
proprietary photo-bioreactor technology to grow, harvest, and
dry/extract micro-algae indoors, which is extremely useful for its
medicinal properties. 
Mobile Health One: Mobile Health One is a national health care
communications technology company founded by respected neurosurgeon
and successful entrepreneur John Abrahams, M.D. The Company has
developed MDChat, a cloud-based mobile communication system that lets
health care providers communicate instantly with one another in a
secure environment. MDChat is positioned to provide a new model for
workflow productivity in the health care industry. It unifies
professionals within and between organizations into a collective
communications environment that will ultimately lead to better
patient care." 
Wow Factor: Mobile Health One, Inc. develops mobile, on-demand
HIPAA-compliant systems that unify health care professionals within
and between organizations by simplifying communications to
accelerate, consolidate, and control information sharing.  
First Wave Technologies Inc.: First Wave Technologies is a newly
formed technology firm established to assist researchers and
corporations advance their technologies to market. However, more
importantly than providing "just money", First Wave's model is to
provide a complete management team that can partner with researchers
to accelerate introduction of ideas into the hands of customers. 
Wow Factor: First Wave Technologies is a medical device facilitation
business, with two initial products, the First Crush automated pill
crusher in order to make them digestible due to the high demand by
the growing population of senior citizens; and a respiratory device
conversion and amplification technology that turns a ventilator into
the equivalent of a $150,000 anesthesia machine. 
Raland Therapeutics: Raland Therapeutics transforms novel ideas into
innovative devices to provide researchers with powerful tools to
translate cellular data to the preclinical phase. Its experience and
passion drive the Company to solve complex biomedical problems that
ultimately improve patient care. Advancing innovation from the bench
to the bedside, Raland understands the science, compliance, and the
business of biomedical devices.  
Wow Factor: Raland Therapeutics, Inc. has developed diagnostic and
therapeutic devices that use implantable biosensors to provide real
time, in-vivo monitoring of biological signaling and cellular
responses while minimizing animal handling, labor requirements, cell
culture/pathologic processing and capital costs. 
CytoSorbents Corporation: CytoSorbents Corporation (OTCQB: CTSO) is a
critical care focused company using blood purification to treat
life-threatening illnesses and to control excessive, potentially
deadly inflammation that could otherwise cause the failure of vital
organs. 
Wow Factor: CytoSorbents has been awarded contracts from both DARPA
and the US Army, and continues to invest significantly in its
research and development pipeline. One of its most advanced products
under development is HemoDefend, a blood purification technology
platform for the blood transfusion industry intended to reduce
transfusion reactions and improve the safety of "old" blood by
removing many substances, such as antibodies, free hemoglobin and
inflammatory mediators that can cause potentially serious and
sometimes fatal transfusion reactions. 
LICA, in collaboration with The Center for Advanced Sensor
Technologies at Stony Brook University, will host the Health Care
Capital Forum on March 8, 2013 from 8:00 a.m. to 10:30 a.m. at 68
South Service Road, Melville, NY. At the capital forum, the selected
health care presenting companies will showcase their technologies,
products and services. A panel of investors and industry experts will
observe these presentations and provide their insights on the
development of the health care industry and its investments
prospects. For more information about the event, please contact LICA
today or register online. 
About the Long Island Capital Alliance: 
Since 1984, the Long Island Capital Alliance (www.licapital.org),
formerly known as Long Island Venture Group, has been promoting
business growth on Long Island. LICA seeks to create a productive and
business-friendly environment that will afford area businesses access
to the resources necessary to compete successfully in today's
markets. LICA serves as a focal point for the exchange of ideas among
new and existing business enterprises, successful entrepreneurs,
investors, and service providers. Through quarterly capital forums
and special meetings, LICA brings together members of the region's
business community, and has been recognized as the place to turn to
when small businesses need equity, debt, or other financing, or for
investors to find an attractive investment opportunity. 
LICA's mission is to encourage economic development on Long Island by
facilitating capital formation for a broad range of companies in
various industries, from early stage to mature middle market closely
held and publicly-traded businesses. LICA accomplishes this primarily
through education, networking, quarterly capital forums, periodic
special educational meetings, and alliances with other regional
organizations. LICA brings together members of the region's business
community and serves as the finance arm for significant local
business and organizations. 
For more information on LICA and its next event, please contact LICA
today or register online. 
About The Center for Advanced Sensor Technologies at Stony Brook
University:
 The New York State Center for Advanced Sensor Technology
at Stony Brook University provides intellectual, logistical, and
material resources for the development of new product technologies by
facilitating R&D partnerships between New York companies with an
in-state footprint and university researchers. The important outcomes
are new jobs, new patents, training of students in company product
matters, and improved competitiveness for New York State businesses.  
Contact:
Jordan Darrow
Darrow Associates, Inc.
(631) 367-1866 
jdarrow@darrowir.com